DavidNagelMDPhD(He/Him)
Pulmonology • Rochester, NYCritical Care Medicine, Interstitial Lung Diseases
Assistant Professor
Dr. Nagel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 Elmwood Ave
Department of Pulmonary and Critical Care Medicine
Rochester, NY 14642Phone+1 585-275-4161Fax+1 585-273-1171- Is this information wrong?
Summary
- Dr. David Nagel is a pulmonologist in Rochester, NY and is affiliated with Strong Memorial Hospital of the University of Rochester. He received his medical degree from University of Rochester School of Medicine and Dentistry and has been in practice 6 years. He specializes in critical care medicine and interstitial lung diseases and is experienced in interstitial lung disease. He has more than 10 publications and 8 citings.
Education & Training
University of RochesterFellowship, Pulmonary Disease and Critical Care Medicine, 2015 - 2018
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalChief Residency, Internal Medicine, 2014 - 2015- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2011 - 2014
University of Rochester School of Medicine and DentistryClass of 2011
Certifications & Licensure
NY State Medical License 2016 - 2025
NH State Medical License 2011 - 2016
VT State Medical License 2014 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial Start of enrollment: 2020 Dec 17
- Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis Start of enrollment: 2021 Jun 01
- Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2024 Jan 31
Publications & Presentations
PubMed
- 4 citationsAssociation between weight loss and mortality in idiopathic pulmonary fibrosis.Aleksandr Kalininskiy, Ashley Rose Rackow, David Nagel, Daniel Croft, Heather McGrane-Minton, Robert Matthew Kottmann> ;Respiratory Research. 2022 Dec 24
- 3 citationsThe Novel Small Molecule BTB Inhibits Pro-Fibrotic Fibroblast Behavior though Inhibition of RhoA Activity.Ashley R Rackow, David J Nagel, Gregory Zapas, Ryan S Clough, Patricia J Sime, R Matthew Kottmann> ;International Journal of Molecular Sciences. 2022 Oct 8
- 3 citationsCell-Type-Specific Effects of the Ovarian Cancer G-Protein Coupled Receptor (OGR1) on Inflammation and Fibrosis; Potential Implications for Idiopathic Pulmonary Fibrosis.David J Nagel, Ashley R Rackow, Wei-Yao Ku, Tyler J Bell, Patricia J Sime, Robert Matthew Kottmann> ;Cells. 2022 Aug 16
- Join now to see all
Press Mentions
How Fixes for N.H.'s Opioid Crisis May Be Hurting Those with Chronic PainSeptember 20th, 2017
Professional Memberships
- Member
- Member
Hospital Affiliations
Strong Memorial Hospital of the University of RochesterRochester, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
